Whether it's the cost, side effects or you've simply lost the weight you were looking to lose, questions emerge when deciding to stop taking GLP-1 medications, such as Wegovy, Ozempic, and others
Among participants whose weight was recorded at week 64: 79.2% lost at least 5% of their starting body weight 63.0% lost at least 10% 50.0% lost at least 15% 29.7% (Around 1 in 3) lost 20% Understanding the Wegovy Pill Clinical Trials Below, we've laid out some of the common percentages you're likely to see given for Wegovy Pill weight loss expectations and what they mean, using the commonly cited OASIS-4 trial
Update in: Cochrane Database Syst Rev
Because your dose may need to go up over time, PlexusDx's flat-price model means your investment remains consistent even as your medication strength increases
The early discomfort is real for some patients, but for most it is manageable when the titration is paced carefully and the doctor stays involved
PlexusDx maintains flat monthly pricing regardless of dose level, so optimization never comes with unexpected cost increases